Scadenza: 26 March 2021
Scadenze successive:
SUBMISSION DEADLINE: April 23rd, 2021,
Topic:
This call is in support of projects focusing on the development of therapies for the treatment
of rare diseases and/or diseases of proven genetic origin (either monogenic or polygenic
forms).
Projects should prioritize rare and/or genetic disease indications but can expand to more
common diseases.
Ente finanziatore:
Sofinnova Partners e Fondazione Telethon
Durata del progetto: 1-3 Years
Chi può partecipare:
Researchers working in a public or private, not for profit or profit research institution, who
are interested in establishing a start-up in Italy
Partenariato: Non obbligatorio
Status:
Chiuso
Quota finanziabile:
max 1.5 milion €
Topic:
This call is in support of projects focusing on the development of therapies for the treatment
of rare diseases and/or diseases of proven genetic origin (either monogenic or polygenic
forms).
Projects should prioritize rare and/or genetic disease indications but can expand to more
common diseases.
Who can participate:
Researchers working in a public or private, not for profit or profit research institution, who
are interested in establishing a start-up in Italy
Programme:
Consortium: Not required
Status: Aperto
Total budget:
Funding rate:
max 1.5 milion €
